KOREA WHO
-
-
-
CEO of Samsung Biologics
John Rim
American Citizen with Global Connections, Emphasizing Responsibility to Employees
-
Last Updated on Jan 15, 2024
-
CEO of Samsung Biologics
Life Summary
John Rim is the President and CEO of Samsung Biologics. He also serves as the Chairman of the Board.
He is working to elevate Samsung Biologics to the top position globally in contract development and manufacturing organization (CDMO) through the expansion of biopharmaceutical production capacity and technological development.
Born in South Korea in October 1961, he later immigrated to the United States.
He is a U.S. citizen and graduated from Columbia University with a degree in Chemical Engineering.
He earned a Master's degree in Chemical Engineering from Stanford University and completed his MBA at Northwestern University's Kellogg School of Management.
He worked as an executive at the U.S. subsidiaries of multinational pharmaceutical companies.
He has set a goal to elevate Samsung Biologics' contract development (CDO), contract research (CRO), and contract manufacturing (CMO) capabilities to the highest level globally within ten years.
He emphasizes responsibility and a sense of mission to employees and strives to create a corporate culture with active communication.
### Keywords
#JohnRim #SamsungBiologics #CEO #biopharmaceuticals #CDMO #biotech #leadership #globalbusiness #corporateculture #innovation
He is working to elevate Samsung Biologics to the top position globally in contract development and manufacturing organization (CDMO) through the expansion of biopharmaceutical production capacity and technological development.
Born in South Korea in October 1961, he later immigrated to the United States.
He is a U.S. citizen and graduated from Columbia University with a degree in Chemical Engineering.
He earned a Master's degree in Chemical Engineering from Stanford University and completed his MBA at Northwestern University's Kellogg School of Management.
He worked as an executive at the U.S. subsidiaries of multinational pharmaceutical companies.
He has set a goal to elevate Samsung Biologics' contract development (CDO), contract research (CRO), and contract manufacturing (CMO) capabilities to the highest level globally within ten years.
He emphasizes responsibility and a sense of mission to employees and strives to create a corporate culture with active communication.
### Keywords
#JohnRim #SamsungBiologics #CEO #biopharmaceuticals #CDMO #biotech #leadership #globalbusiness #corporateculture #innovation